Perspective Therapeutics (CATX) Long-Term Debt Issuances (2010 - 2026)
Perspective Therapeutics (CATX) posted Long-Term Debt Issuances of $15000.0 for Q1 2026, up 15.38% sequentially from $13000.0 in Q4 2025, and up 15.38% YoY from $13000.0 in Q1 2025.
Perspective Therapeutics (CATX) Long-Term Debt Issuances (2010 - 2026) Analysis & Trends
Perspective Therapeutics has reported Long-Term Debt Issuances for 6 years, with the latest figure at $15000.0 in Q1 2026.
- Quarterly Long-Term Debt Issuances rose 15.38% year-over-year to $15000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $54000.0 (up 10.2% YoY) and the FY2025 annual result came in at $52000.0, up 8.33% from the prior year.
- Long-Term Debt Issuances rose to $15000.0 in Q1 2026 per CATX's latest filing, from $13000.0 in the prior quarter.
- Over five years, Long-Term Debt Issuances peaked at $21000.0 in Q3 2023 and troughed at $8000.0 in Q2 2024.
- A 4-year average of $14076.9 and a median of $13000.0 in 2025 frame the typical range for Long-Term Debt Issuances.
- The sharpest annual moves came in 2024 and 2025: Long-Term Debt Issuances plunged 60.0% in 2024, then soared 62.5% in 2025.
- Over 4 years, Long-Term Debt Issuances stood at $12000.0 in 2023, then changed by 0.0% to $12000.0 in 2024, then climbed by 8.33% to $13000.0 in 2025, then rose by 15.38% to $15000.0 in 2026.
- According to Business Quant data, Long-Term Debt Issuances over the past three periods registered $15000.0, $13000.0, and $13000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -33.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | - |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 109.26 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | - |
| 10 | Perspective Therapeutics | 396.34 Mn | 396.34 Mn | - | 13,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13,000.00 |
| Jun 30, 2026 | 13,000.00 |
| Mar 31, 2026 | 15,000.00 |
| Mar 31, 2026 | 15,000.00 |
| Dec 31, 2025 | 13,000.00 |
| Dec 31, 2025 | 13,000.00 |
| Sep 30, 2025 | 13,000.00 |
| Sep 30, 2025 | 13,000.00 |
| Jun 30, 2025 | 13,000.00 |
| Jun 30, 2025 | 13,000.00 |
| Mar 31, 2025 | 13,000.00 |
| Mar 31, 2025 | 13,000.00 |
| Dec 31, 2024 | 12,000.00 |
| Dec 31, 2024 | 12,000.00 |
| Sep 30, 2024 | 16,000.00 |
| Sep 30, 2024 | 16,000.00 |
| Jun 30, 2024 | 8,000.00 |
| Jun 30, 2024 | 8,000.00 |
| Mar 31, 2024 | 12,000.00 |
| Mar 31, 2024 | 12,000.00 |